Company Filing History:
Years Active: 2017-2018
Title: Pam Van Ry: Innovator in Muscular Dystrophy Research
Introduction
Pam Van Ry is a prominent inventor based in Reno, NV (US), known for her significant contributions to the field of muscular dystrophy research. With a total of 2 patents, she has developed innovative methods aimed at diagnosing, prognosing, and treating various forms of muscular dystrophy. Her work is crucial in enhancing the quality of life for individuals affected by these conditions.
Latest Patents
Pam Van Ry's latest patents include groundbreaking methods for diagnosing, prognosing, and treating muscular dystrophy. One patent discloses methods for determining the effectiveness of agents used in the treatment of muscular dystrophy. It also provides techniques for enhancing muscle regeneration, repair, or maintenance by administering galectin, such as Galectin-1 and/or Galectin-3. Another patent focuses on methods for treating muscular dystrophy, including diagnosing subjects with specific types of muscular dystrophy, such as merosin-deficient congenital muscular dystrophy Type 1A (MDC1A) and Duchenne muscular dystrophy (DMD). These patents represent a significant advancement in the understanding and treatment of muscular dystrophy.
Career Highlights
Pam Van Ry is affiliated with the University of Nevada, where she conducts her research and develops her innovative methods. Her work has garnered attention in the scientific community, contributing to advancements in the treatment of muscular dystrophy.
Collaborations
Pam collaborates with notable colleagues, including Dean Burkin and Ryan Wuebbles, who share her commitment to advancing research in muscular dystrophy. Their combined expertise enhances the impact of their work in this critical area of health.
Conclusion
Pam Van Ry is a dedicated inventor whose innovative methods are paving the way for improved diagnosis and treatment of muscular dystrophy. Her contributions are vital in the ongoing fight against this challenging condition, and her work continues to inspire advancements in medical research.